Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome

QR Code

Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome

Myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS) affects approximately 1% of the general population. It is a chronic, disabling, multi-system disease for which there is no effective treatment. This is probably related to the limited knowledge about its origin. Here, we summarized the c...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Manuel Ruiz-Pablos, Bruno Paiva, Rosario Montero-Mateo, Nicolas Garcia, Aintzane Zabaleta
Format:	article
Langue:	EN
Publié:	Frontiers Media S.A. 2021
Sujets:	chronic fatigue syndrome myalgic encephalomyelitis EBV EBNA-1 HLA-II alleles cancer CD4+ CTL Immunologic diseases. Allergy RC581-607
Accès en ligne:	https://doaj.org/article/40b36b3f5a574fb7adff4134fe44b6a4
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?
par: Iñigo Murga, et autres
Publié: (2021)

An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
par: Klaus J. Wirth, et autres
Publié: (2021)

Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients
par: Nguyen,T., et autres
Publié: (2016)

Back to the Future? Immunoglobulin Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
par: Helen Brownlie, et autres
Publié: (2021)

Associations Between Psychological and Immunological Variables in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Systematic Review
par: Emilie F. W. Raanes, et autres
Publié: (2021)

Fatigue biomedicine, health & behavior.

Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP<sub>2</sub> in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
par: Stanley Du Preez, et autres
Publié: (2021)

Epstein Barr Virus Exploits Genetic Susceptibility to Increase Multiple Sclerosis Risk
par: Fabienne Läderach, et autres
Publié: (2021)

Chronic Fatigue Syndrome: A Case Report Highlighting Diagnosing and Treatment Challenges and the Possibility of Jarisch–Herxheimer Reactions If High Infectious Loads Are Present
par: Rachel K. Straub, et autres
Publié: (2021)

mapMECFS: a portal to enhance data discovery across biological disciplines and collaborative sites
par: Ravi Mathur, et autres
Publié: (2021)

Kaposi’s Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma
par: Mark Manzano, et autres
Publié: (2020)

PRESENCIA DEL MARCADOR LMP-1 DEL VIRUS EPSTEIN-BARR EN LINFOMAS DE CANINOS
par: L. C. Veloza, et autres
Publié: (2017)

Air-Liquid Interface System To Understand Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma
par: Sharon E. Hopcraft, et autres
Publié: (2018)

Identifying Epstein–Barr virus peptide sequences associated with differential IgG antibody response
par: Anna E. Coghill, et autres
Publié: (2022)

Detecting and Monitoring Porcine Hemagglutinating Encephalomyelitis Virus, an Underresearched Betacoronavirus
par: Juan Carlos Mora-Díaz, et autres
Publié: (2020)

Epstein-Barr Virus-Associated Carcinoma of the Larynx: A Systematic Review with Meta-Analysis
par: Marcos Antonio Pereira de Lima, et autres
Publié: (2021)

Inmunohistoquímica en un caso de encefalitis por virus de Epstein Barr
par: Calore,Edenilson E, et autres
Publié: (2012)

Interplay between IL-10, IFN-γ, IL-17A and PD-1 Expressing EBNA1-Specific CD4<sup>+</sup> and CD8<sup>+</sup> T Cell Responses in the Etiologic Pathway to Endemic Burkitt Lymphoma
par: Catherine S. Forconi, et autres
Publié: (2021)

Reevaluating the Impact of Epstein-Barr Virus Noncoding RNAs on the Interferon Response
par: Eain A. Murphy
Publié: (2021)

Comparative analysis of HLA II allele and genotype frequency distribution in patients with type 1 diabetes mellitus and autoimmune thyroiditis
par: Ekaterina Alexandrovna Repina, et autres
Publié: (2013)

Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality
par: Sara R. Selitsky, et autres
Publié: (2018)

Regulation of Epstein-Barr Virus Life Cycle and Cell Proliferation by Histone H3K27 Methyltransferase EZH2 in Akata Cells
par: Takaya Ichikawa, et autres
Publié: (2018)

Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell Cycle
par: Mark R. Eichelberg, et autres
Publié: (2019)

Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 ‘long-haulers’?
par: Emily Wood, et autres
Publié: (2021)

Epstein-Barr Virus Induced Cytidine Metabolism Roles in Transformed B-Cell Growth and Survival
par: Jin Hua Liang, et autres
Publié: (2021)

Competitive Endogenous RNA Landscape in Epstein-Barr Virus Associated Nasopharyngeal Carcinoma
par: Xiandong Lin, et autres
Publié: (2021)

FUCTIONAL OUTCOME OF ACUTE DISSEMINATED ENCEPHALOMYELITIS IN CHILDREN
par: Muhammad Zia Ur Rehman, et autres
Publié: (2018)

Distribution patterns of HLA-A<sup>*</sup>, B<sup>*</sup>, DRB1<sup>*</sup> allele groups among persons who underwent COVID-19
par: L. N. Bubnova, et autres
Publié: (2021)

HLA diversity in the Russian population assessed by next generation sequencing
par: E. G. Khamaganova, et autres
Publié: (2021)

Breast cancer immunophenotype and its relationship with haematopoiesis
par: Denis A. Ryabchikov, et autres
Publié: (2021)

BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon <italic toggle="yes">De Novo</italic> Infection
par: Natsuno Konishi, et autres
Publié: (2018)

DYNAMICS OF CIRCULATING AND EXPRESSED CYTOKINES UPON INDUCTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
par: Yu. L. Zhitnukhin, et autres
Publié: (2014)

HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients
par: Geok Wee Tan, et autres
Publié: (2021)

High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.
par: Ekua W Brenu, et autres
Publié: (2014)

Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma
par: Osman Cen, et autres
Publié: (2018)

Epstein-Barr Virus Epitope–Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor α and β Repertoires
par: Anna Gil, et autres
Publié: (2020)

Hormones in experimental autoimmune encephalomyelitis (EAE) animal models
par: Ghareghani Majid, et autres
Publié: (2021)

Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation
par: Suzan Fares, et autres
Publié: (2019)

Primary Peripheral Epstein-Barr Virus Infection Can Lead to CNS Infection and Neuroinflammation in a Rabbit Model: Implications for Multiple Sclerosis Pathogenesis
par: Asma Hassani, et autres
Publié: (2021)

Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders
par: Elham Ahmadi, et autres
Publié: (2021)